All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 120 of 206 pages ‹ First < 118 119 120 121 122 > Last ›
HSL8048
 Bush A.
 Clinical trials research in pediatrics: strategies for effective collaboration between investigator sites and the pharmaceutical industry.
 
Paediatr Drugs 2006;8:(5):271-7
 
HSL8053
 Society for Clinical Trials Board of Directors.
 The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients.
 
Clin Trials 2006;3:(2):154-7
 
http://ctj.sagepub.com/cgi/reprint/3/2/154
HSL8213
 Elimimian JU, Gilmore JM, Singletary TJ.
 Global marketing of cholesterol-lowering drugs as therapy.
 
J Hosp Mark Public Relations 2006;16:(1-2):15-28
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17194684&query_hl=11&itool=pubmed_DocSum
HSL8272
 Kassirer JP.
 Author's Reply to Readers' Responses to 'Physicians on the Take'
 Medscape General Medicine 2006;8:(2):40
 
http://www.medscape.com/viewarticle/531613
HSL8278
 Cohen JC, Illingworth P, Schuklenk U, Eds .
 The Power of Pills
 London: Pluto Press 2006
 
http://www.plutobooks.com/cgi-local/nplutobrows.pl?chkisbn=9780745324029&main=&second=&third=&foo=../ssi/ssfooter.ssi
HSL8425
 Public Library Of Science Medicine.
 Drowning or thirsting: the extremes of availability of medical information.
 
J Pain Palliat Care Pharmacother 2006;20:(4):113-4
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17182520&query_hl=12&itool=pubmed_DocSum
HSL8427
 DeLorme DE, Huh J, Reid LN.
 Age differences in how consumers behave following exposure to DTC advertising.
 
Health Commun 2006;20:(3):255-65
 
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2003_5
HSL8430
 Croll TP, Swanson BZ Jr.
 Victorian era esthetic and restorative dentistry: an advertising trade card gallery.
 
J Esthet Restor Dent 2006;18:(5):235-54;
 
http://www.blackwell-synergy.com/doi/full/10.1111/j.1708-8240.2006.00031.x
HSL8518
 Jureidini J, Tonkin A.
 Overuse of antidepressant drugs for the treatment of depression.
 
CNS Drugs 2006;20:(8):623-32
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16863268&query_hl=29&itool=pubmed_DocSum
HSL8523
 Jureidini JN, Mansfield PR.
 The scope of the problem of the relationship between drug companies and doctors
  Maitra B, Timimi S. Critical Voices in Child and Adolescent Mental Health London: Free Association Books 2006
 
http://www.fabooks.com/book.php?id=434
HSL8685
 Smith JL, Cervero RM, Valentine T.
 Impact of commercial support on continuing pharmacy education.
 J Contin Educ Health Prof 2006 Fall;26:(4):302-12
 
http://www3.interscience.wiley.com/cgi-bin/abstract/113515268/ABSTRACT?CRETRY=1&SRETRY=0
HSL8789
 Ellison SF, Wolfram C.
 Coordinating on lower prices: pharmaceutical pricing under political pressure.
 
Rand J Econ 2006 Sum;37:(2):324-40
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17290546&query_hl=6&itool=pubmed_DocSum
HSL8823
 Shah S.
 The Body Hunters:Testing New Drugs on the World's Poorest Patients
 New York: The New Press 2006
 
http://www.thenewpress.com/index.php?option=com_title&task=view_title&metaproductid=1301
HSL9020
 Williams HC, Naldi L, Paul C, Vahlquist A, Schroter S, Jobling R.
 Conflicts of interest in dermatology.
 
Acta Derm Venereol 2006;86:(6):485-97
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17106594&query_hl=12&itool=pubmed_DocSum
HSL9070
 Outterson K, Smith R.
 Counterfeit Drugs: The Good, the Bad and the Ugly
 Albany Law Journal of Science and Technology 2006;15:
 
http://ssrn.com/abstract=926985 
HSL9086
 Permanand G.
 EU Pharmaceutical Regulation: The Politics of Policy-Making 
 : Manchester University Press 2006
 
http://www.amazon.com/EU-Pharmaceutical-Regulation-Politics-Policy-Making/dp/0719072727/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1175307106&sr=1-1
HSL9167
 Lietzan E.
 Advisory committees at FDA: the Hinchey Amendment and 'conflict of interest' waivers.
 J Health Law 2006 Fal;39:(4):415-49
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17402656&query_hl=3&itool=pubmed_DocSum
HSL9171
 Seitz R.
 EU procedures for marketing authorization of pharmaceutical products.
 Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2006;(95):60-3;
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17393723&query_hl=10&itool=pubmed_docsum
HSL9273
 Denham BE.
 The Anabolic Steroid Control Act of 2004: a study in the political economy of drug policy.
 
J Health Soc Policy 2006;22:(2):51-78
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17255072&query_hl=19&itool=pubmed_DocSum
HSL9276
 Zetin M, Hoepner CT, Bjornson L.
 Rational antidepressant selection: applying evidence-based medicine to complex real-world patients.
 
Psychopharmacol Bull 2006;39:(1):38-104
 
http://www.medworksmedia.com/psychopharmbulletin/pdf/18/038-104_PB_V39N1_Zetin.pdf
HSL10058
 Peltier B, Dower JS Jr.
 The ethics of adopting a new drug: articaine as an example.
 
J Am Coll Dent 2006 Fal;73:(3):11-20
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17477213&query_hl=15&itool=pubmed_DocSum
HSL10760
 Jacobson M, O’malley AJ, Earle CC, Pakes J, Gaccione P, Newhouse JP.
 Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients? 
 Health Affairs 2006;25:(2):437-443
 
http://content.healthaffairs.org/cgi/content/full/25/2/437
HSL10956
 Henderson JK, Cassady Q.
 Drug deals in 2006: cutting edge legal and regulatory issues in the pharmaceutical industry.
 
Ann Health Law 2006 Win;15:(1):107-49,
 
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17552135&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10989
 Breggin P.
 Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs
 Ethical Human Psychology and Psychiatry 2006 Fall/Wi;8:(3):201-215
 
http://www.breggin.com/spellbinding_psychiatric_drugs.pdf
HSL19037
 Woloshin S, Schwartz LM.
 Media reporting on research presented at scientific meetings: more caution needed.
 Med J Aust 2006 5;184:(11):576-80
 
http://www.mja.com.au/public/issues/184_11_050606/wol10024_fm.html
HSL11190
 Croll TP, Swanson BZ Jr.
 Dental trade cards XXII. 19th century dentistry advertising trade cards
 J Hist Dent. 2006;
 
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17354677&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11299
 Foote M, Soskin K.
 Medical writing departments in biopharma companies: how to establish a department.
 
Biotechnol Annu Rev 2006;12:387-400:
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7CTS-4M345D7-H&_user=10&_coverDate=12%2F31%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0e29821f66da6f7094216ae75104ec02
HSL11367
 Metzl JM, Howell JD.
 Great moments: authenticity, ideology, and the telling of medical "history".
 
Lit Med 2006 Fal;25:(2):502-21
 
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17649844&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11544
 Dinan W, Miller D.
 Transparency in EU Decision Making, Holding Corporations to Account: Why the ETI needs mandatory Lobbying Disclosure
  Spencer T, McGrath C. Challenge and Response:  Essays on Public Affairs and Transparency Brussels: Landmarks Publishing 2006
 
HSL11631
 Kauffman JM.
 Malignant Medical Myths: Why MEdical Treatment Causes 200,000 Deaths in the USA each Year, and How to Protect Yourself 
 West Conshohocken, PA: Infinity Publishing 2006
 
http://www.amazon.com/Malignant-Medical-Myths-Treatment-Yourself/dp/0741429098
HSL11632
 King S.
 Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy 
 Minneapolis, MN: University of Minnesota Press 2006
 
http://www.amazon.ca/Pink-Ribbons-Inc-Politics-Philanthropy/dp/0816648980/ref=pd_bbs_sr_1/701-8847708-8409917?ie=UTF8&s=books&qid=1191166358&sr=8-1
HSL11764
 Lee O, Kim BC, Han S.
 The portrayal of older people in television advertisements: a cross-cultural content analysis of the United States and South Korea.
 
Int J Aging Hum Dev 2006;63:(4):279-97
 
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17191435
HSL11870
  Light D.
 Basic research funds to discover important new drugs: who contributes how much?
  Burke MA, De Francisco A. Monitoring Financial Flows for Health Research 2005: Behind the Global Numbers Geneva: Global Forum for Health Research 2006
 
http://web.archive.org/web/20090610012035/http://www.bioethics.upenn.edu/People/?last=Light&first=Donald
HSL13051
 IMS Health Canada
 Drug Treatment insights: Hormone Replacement Therapy
 : IMS Health Canada 2006
 
http://www.imshealthcanada.com/vgn/images/portal/cit_40000873/6/1/79032750Insights01En061127.pdf
HSL13230
  Evans I, Thornton H, Chalmers I.
 Testing treatments: better research for better healthcare.
 London: British Library 2006
 
http://www.jameslindlibrary.org/pdf/testing-treatments.pdf
HSL19036
 Kallen AJ, Wilson CT, Russell MA, Larson RJ, Davies L, Sirovich BE, Schwartz LM, Woloshin S, Welch HG.
 Group writing of letters to the editor as the goal of journal club.
 JAMA 2006 6;296:(9):1053-4
 
http://jama.ama-assn.org/content/296/9/1053.long
HSL14112
 Velo G, Bassi M, Apolone G, Rossi M, Buscone N, et al.
 Informazione scientifica sul farmaco: Risultati di un indagine pilota su un campione di medici di medicina generale [Provision of scientific information on drugs: Results of a pilot survey of general medicine doctors]
 Economia & Politica del Farmaco 2006;7:13Â19
 
HSL14117
 Delbaere M, Smith MC.
 Health care knowledge and consumer learning: the case of direct-to-consumer drug advertising.
 Health Mark Q 2006;23:(3):9-29
 
http://www.ncbi.nlm.nih.gov/pubmed/18681197
HSL14773
 Sheehan K.
 Consumer Friendly or Reader Hostile? An Evaluation of the Readability of DTC Print Ads?
 Health Mark Q. 2006;23:(4):1-16.
 
http://www.ncbi.nlm.nih.gov/pubmed/19042509
HSL16004
 BELLI CV
 Novas perspectivas no controle dos produtos para saúde no Brasil : a visão do setor regulador e do setor regulado
 2006
 
http://www4.ensp.fiocruz.br/visa/biblioteca/publicacoes.cfm?tipo=448&pub=1854
HSL16005
 Da Silva Nobre PF
 Estado, direito e saúde: considerações sobre a formalização do direito sanitário e sobre o conceito de vigilância sanitária
 RIO DE JANEIRO: Dissertação de Mestrado apresentada à Escola Nacional de Saúde Pública 2006
 
http://www4.ensp.fiocruz.br/visa/biblioteca/publicacoes.cfm?tipo=448&pub=1738
HSL16337
 Dukes G
 The Law and Ethics of the Pharmaceutical Industry San Diego: Elsevier 2006
 
http://www.elsevier.com/wps/find/bookdescription.cws_home/705824/description#description
HSL18428
 Civaner M
 Marketing techniques of pharmaceutical companies and their effects to physicians
 Medikal Etik - 6 İstanbul: Yüce Yayım 200662-72
 
HSL20381
 Spurgeon D
 US study questions use of black box warning on antidepressants
 BMJ 2006;332:
 
http://www.bmj.com/content/332/7533/68.2
HSL20555
 Glass HE, Dalton DW
 Profiles of Phase IV Investigators and Subsequent Prescribing of the Study Drug
 Journal of Pharmaceutical Marketing & Management 2006;17:(3,4):3-17
 
http://informahealthcare.com/doi/abs/10.3109/J058v17n03_02
HSL4882
 Chabot JM.
 [Studies of medical students and residents].
 
Rev Prat 2005 Dec 31;55:(20):2281-2
 
HSL3486
 Bridges A.
 Registry for Accutane Patients Debuts 
 Associated Press 2005 Dec 30
 
http://www.msnbc.msn.com/id/10654280/
HSL3490
 Lucas S.
 The Making of Mental Patients- Inside TeenScreen
 Counterpunch 2005 Dec 30
 
http://www.counterpunch.org/lucas12302005.html
HSL4854
 Activists lift boycott of Abbott Laboratories.
 AIDS Policy Law 2005 Dec 30;21:(1):2
 
HSL3446
 NYC Health Dept Warns Against Use Of Herbal Medicine Products Made In India That Contain Lead Or Mercury
 Medical News Today 2005 Dec 29
 
http://www.medicalnewstoday.com/medicalnews.php?newsid=35467
HSL7415
 Haug C, Gotzsche PC, Schroeder TV.
 Registries and registration of clinical trials.
 
N Engl J Med 2005 Dec 29;353:(26):2811-2
 
http://content.nejm.org/cgi/content/full/353/26/2811
HSL7416
 Zarin DA, Tse T, Ide NC.
 Trial Registration at ClinicalTrials.gov between May and October 2005
 N Engl J Med 2005 Dec 29;353:(26):2779-87
 
http://content.nejm.org/cgi/content/full/353/26/2779
HSL3485
 MacDonald G.
 Backstory: A pill they won't swallow
 The Christian Science Monitor 2005 Dec 28
 
http://www.csmonitor.com/2005/1228/p20s01-lire.html
HSL3257
 Mathews A, Wonacott P.
 At Medical Journal, Editor Finds Truth Hard to Track Down
 The wall street journal 2005 Dec 27
 
http://online.wsj.com/article_email/SB113565052512831921-lMyQjAxMDE1MzI1NzYyNTcwWj.html 
HSL3258
 Herper M.
 Sneak Peek 2006  -  Matthew Herper On The Drug Industry 
 Forbes.com 2005 Dec 27
 
http://www.forbes.com/2005/12/12/health-2006-predictions-sneakpeek_sp06_13_mherper_health.html?partner=yahootix
HSL3259
 Romano B.
 Caution tempers hopes for biotech
 The Seattle Times 2005 Dec 27
 
http://seattletimes.nwsource.com/html/businesstechnology/2002705670_biotechyear27.html
HSL3260
 Medicare mess 
 NorthJersey.com 2005 Dec 27
 
http://www.northjersey.com/page.php?qstr=eXJpcnk3ZjcxN2Y3dnFlZUVFeXkxNCZmZ2JlbDdmN3ZxZWVFRXl5Njg0NDEzNw==
HSL3262
 DTC Advertising and Promotion: The Changing Environment
 FDAnews 2005 Dec 27
 
http://www.fdanews.com/wbi/bookstore/2057-1.html?p=DRUGDT
HSL4742
 Fu D, Pammolli F, Buldyrev SV, Riccaboni M, Matia K, Yamasaki K, Stanley HE.
 The growth of business firms: theoretical framework and empirical evidence.
 
Proc Natl Acad Sci U S A 2005 Dec 27;102:(52):18801-6
 
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16365284&db=PubMed&url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=16365284
HSL3254
 Agovino T.
 Drugs may face post-approval tests
 Associated Press 2005 Dec 26
 
http://www.philly.com/mld/inquirer/business/13487137.htm
HSL3256
 Solomon J.
 Update 3: Doc Makes Candid Comments on HIV Vaccine 
 Forbes.com 2005 Dec 26
 
http://www.islandmix.com/backchat/f9/pharmaceutical-companies-purposely-delaying-finding-cure-aids-114013/
HSL3255
 Curran J.
 Vioxx Judge Sees Never-Ending Docket
 Associated Press 2005 Dec 25
 
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=9010180#
HSL3265
 Solomon J.
 NIH Medical Safety Officer Reinstated
 Associated Press 2005 Dec 24
 
http://abcnews.go.com/Politics/wireStory?id=1439375 
HSL3261
 Fincher M.
 "It’s a national convention where our reps see  'no see' physicians."
 American Academy of Family Physicians 2005 Dec 23
 
http://www.aafp.org
HSL3264
 Meikle J.
 Judge orders health trust to fund interim course of Herceptin for cancer patient  
 The Guardian ( UK) 2005 Dec 22
 
http://www.guardian.co.uk/medicine/story/0,11381,1672451,00.html?gusrc=rss
HSL3589
 Brett AS, Zuger A.
 The run on tamiflu--should physicians prescribe on demand?
 N Engl J Med 2005 Dec 22;353:(25):2636-7
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=16371627&dopt=Abstract
HSL13551
 Washburn J.
 Rent-a-Researcher: DID A BRITISH UNIVERSITY SELL OUT TO PROCTER & GAMBLE?
 Slate 2005 Dec 22
 
http://www.slate.com/id/2133061/
HSL3500
 Callahan R.
 Eli Lilly to Pay $36M to Settle Charges
 SFGate ( via AP) 2005 Dec 21
 
http://www2.ljworld.com/news/2005/dec/22/eli_lilly_feds_reach_settlement/
HSL3066
 Manuse A.
 Marketing bipolar treatment
 Metro West Daily News 2005 Dec 20
 
http://web.archive.org/web/20060202114946/http://www.accc.gov.au/content/index.phtml/itemId/716327
HSL3068
 Stomach acid drugs raise risk of diarrhea -study
 Reuters 2005 Dec 20
 
http://today.reuters.com/news/newsArticle.aspx?type=healthNews&storyID=2005-12-20T083230Z_01_ARM005419_RTRUKOC_0_US-HEARTBURN.xml&archived=False
HSL3069
 Harris G.
 F.D.A. Bars Imaging Drug After Deaths 
 New York Times 2005 Dec 20
 
http://www.nytimes.com/2005/12/20/politics/20drug.html 
HSL3070
 Stolberg S.
 Legal Shield for Vaccine Makers Is Inserted Into Military Bill 
 New York Times 2005 Dec 20
 
http://query.nytimes.com/search/query?ppds=bylL&v1=SHERYL%20GAY%20STOLBERG&fdq=19960101&td=sysdate&sort=newest&ac=SHERYL%20GAY%20STOLBERG&inline=nyt-per
HSL3263
 Altman L, Broad W.
 Global Trend: More Science, More Fraud 
 New York Times 2005 Dec 20
 
http://www.nytimes.com/2005/12/20/science/20rese.html?pagewanted=print 
HSL4746
 Gotzsche PC, Johansen HK.
 Misleading statements in industry-sponsored meta-analysis of itraconazole.
 
J Clin Oncol 2005 Dec 20;23:(36):9428-9
 
http://www.jco.org/cgi/content/full/23/36/9428-a
HSL3067
 Gorman B.
 Developing Drug Markets
 The Motley Fool 2005 Dec 19
 
http://www.fool.com/News/mft/2005/mft05121924.htm
HSL3071
 Tanner L.
 Implants, Mastectomies Linked to Problems 
 Associated Press 2005 Dec 19
 
http://web.archive.org/web/20070101054444/http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2005/12/19/national/a132302S36.DTL&type=health
HSL3072
 Alonso-zaldivar R.
 Bird-Flu Bill Slammed as Loophole for Drugmakers
 Los Angeles Times 2005 Dec 19
 
http://www.naturalnews.com/017854.html
HSL3073
 Dijoseph S.
 Strange Goings On at the Cleveland Clinic: Mere Coincidences or Something Far More Problematic?
 newsinferno.com 2005 Dec 19
 
http://www.yourlawyer.com/articles/title/strange-goings-on-at-the-cleveland-clinic-mere-coincidences-or-something-far-more-problematic
HSL3587
 Zarocostas J.
 WTO amendment on generic drugs draws mixed reaction.
 BMJ 2005 Dec 17;331:(7530):1421
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16356954&query_hl=2&itool=pubmed_docsum
HSL4768
 Steele FR.
 Big Pharma's Commedia.
 
Cell 2005 Dec 16;123:(6):971-3
 
http://linkinghub.elsevier.com/retrieve/pii/S0092-8674(05)01321-8
HSL2985
 Harvey K.
 Submission to ACCC re: Application A90994-6 by Medicines Australia re revised Code of Conduct [15th Ed]
 Medreach ( www.medreach.com.au ) 2005 Dec 14
 
http://web.archive.org/web/20060202114946/http://www.accc.gov.au/content/index.phtml/itemId/716327
HSL2981
 Daly R.
 The art of the drug `detailer'
 Toronto Star 2005 Dec 13
 
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Article_Type1&call_pageid=971358637177&c=Article&cid=1134344412615
HSL2983
 Mathews A.
 Ghost Story -  At Medical Journals, Writers Paid by Industry Play Big Role 
 The wall street journal 2005 Dec 13
 
http://online.wsj.com/article/SB113443606745420770.html 
HSL3019
 Barrett A.
 Pfizer's Search for an Answer on Celebrex
 Business Week online 2005 Dec 13
 
http://yahoo.businessweek.com/bwdaily/dnflash/dec2005/nf20051213_7961.htm
HSL3020
 Herper M.
 Saving Celebrex 
 Forbes.com 2005 Dec 13
 
http://www.forbes.com/2005/12/13/pfizer-celebrex-vioxx-cx_mh_1213celebrex.html?partner=yahootix
HSL3484
 Up To $16 Million In Drug Company Stock Investments Conflict 42 U.S. Senators Out of Vaccine Vote, Says FTCR
 U.S. News Wire 2005 Dec 13
 
http://releases.usnewswire.com/GetRelease.asp?id=58052
HSL19836
 Too unlimited
 PMLive.com 2005 Dec 13
 
www.pmlive.com
HSL2982
 Johnson L.
 Merck cuts symptomatic of larger drugmaker issues
 FortWayne.com  ( The Journal Gazette ) 2005 Dec 12
 
http://www.fortwayne.com/mld/journalgazette/business/13388475.htm
HSL2984
 Branswell H.
 CMA faces censorship confrontation
 The Globe and Mail ( Canada) 2005 Dec 12
 
http://www.theglobeandmail.com/servlet/story/RTGAM.20051212.wcma1212/BNStory/National/
HSL3018
 Hansen B.
 Catie & You -  What happens when drugs are found to be unsafe and ineffective? Not much.
 Ragged Edge Magazine online 2005 Dec 12
 
http://www.raggededgemagazine.com/departments/closerlook/000666.html
HSL4840
 Manipulating a journal article.
 NY Times (Print) 2005 Dec 11;WK11:
 
HSL2863
 Herper M.
 Doctor's Orders 
 Forbes.com 2005 Dec 10
 
http://www.forbes.com/free_forbes/2005/1226/052.html?partner=yahoomag
HSL3347
 Barker R.
 New ABPI code provides more information for patients.
 BMJ 2005 Dec 10;331:(7529):1409
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=16269470&dopt=Abstract
HSL3444
 Tanne JH.
 "Cheerleaders Pep Up Drug Sales," New York Times reports
 BMJ 2005 Dec 10;331:1358
 
http://bmj.bmjjournals.com/cgi/content/full/331/7529/1358-b
HSL3445
 Burton B.
 Drug companies told that sponsoring patients' groups might help win approval for their products.
 BMJ 2005 Dec 10;331:(7529):1359
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=16339237&dopt=Abstract
HSL4839
 Berenson A.
 Medical journal criticizes Merck over Vioxx data.
 NY Times (Print) 2005 Dec 9;A1:
 
HSL2862
 Langreth L, Herper M.
 Merck's Deleted Data 
 Forbes.com 2005 Dec 8
 
http://www.forbes.com/technology/sciences/2005/12/08/merck-vioxx-lawsuits_cx_mh_1208vioxx.html
HSL2864
 Crown E.
 Medicare Fraud Settlement Causes Oncologists To Lose Income, USA
 Medical News Today 2005 Dec 8
 
http://www.medicalnewstoday.com/medicalnews.php?newsid=34664 
HSL2858
 Roner L.
 Are details really having the desired effect?
 Eye For Pharma 2005 Dec 7
 
http://www.washington.edu/news/archive/id/6830
HSL2859
 Roner L.
 Using marketing due diligence to connect strategy to share price
 Eye For Pharma 2005 Dec 7
 
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=12/8/2005&news=49001
Page 120 of 206 pages ‹ First < 118 119 120 121 122 > Last ›
